Metabolism and Response to Stress Gene Signatures Reveal Ulcerative Colitis Heterogeneity and Identify Patients With Increased Response to Therapy.

Remicade (infliximab) - J&J

Humira (adalimumab) - AbbVie

andecaliximab (GS-5745) - Gilead

Stelara (ustekinumab) - J&J

http://www.ncbi.nlm.nih.gov/pubmed/40488582

Bruno Sangiorgi; Bryan Linggi; Christopher Ma; Melissa Filice; Michelle I Smith; Niels Vande Casteele; Vipul Jairath; Wendy Teft

Jun 9, 2025